# Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure

Study · id `cardio:ct-nct02271230` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02271230](<https://clinicaltrials.gov/study/NCT02271230>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02271230

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 25871 participants.

## Technical summary

Registry record NCT02271230. Randomized; quadruple masking; primary purpose prevention. Start 2014-08 (registry gives no type); primary completion 2019-12 (actual). Results posted on 2022-03-18.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 25871 participants (enrolled count; ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Primary completion: 2019-12 (actual) (ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Completion: 2019-12 (actual) (ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Results first posted: 2022-03-18 (ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02271230, source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02271230-2022-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
- Condition: Heart Failure
- Intervention (Drug): Vitamin D and fish oil
- Intervention (Dietary supplement): Fish oil (EPA/DHA) alone
- Intervention (Drug): Vitamin D alone
- Intervention (Other): Placebo
- Lead sponsor: Brigham and Women's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)

## Provenance

Content hash: 6cf7ea60b85d4b5272929d5deaa4077e0eae6499394ea3d1cb184b55e92936a6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
